Pfizer Inc and BioNTech SE said on Wednesday their Covid-19 vaccine was safe and effective and produced robust antibody responses in 12- to 15-year-olds, paving the way for them to seek US emergency use authorisation in weeks.
Pfizer hopes that vaccinations of the group could begin before the next school year, Albert Bourla, Pfizer's chairperson and chief executive, said in a statement...
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: